Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $50,000,021 |
Sells | 208 | $144,175,591 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
11 Jan 2024 16:31 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director , 10% | 09 Jan 2024 | Purchase | 1,428,571 | 17.5 | 24,999,992 | I |
14 Dec 2022 16:55 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE OPPORTUNITY FUND II, L.P. | 10% | 12 Dec 2022 | Purchase | 934,581 | 10.7 | 10,000,017 | D |
14 Dec 2022 16:56 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 12 Dec 2022 | Purchase | 934,581 | 10.7 | 10,000,017 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 272,923 | 24.38 | 6,653,863 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 272,923 | 24.38 | 6,653,863 | D |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 08 Mar 2024 | Sale | 202,238 | 25.3 | 5,116,621 | D |
11 Jan 2024 16:31 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director , 10% | 09 Jan 2024 | Purchase | 285,714 | 17.5 | 4,999,995 | I |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 08 Mar 2024 | Sale | 160,670 | 26.72 | 4,293,102 | D |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 15 Feb 2024 | Sale | 175,793 | 23.88 | 4,197,937 | D |
20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 15 Feb 2024 | Sale | 175,793 | 23.88 | 4,197,937 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 152,244 | 24.83 | 3,780,219 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 152,244 | 24.83 | 3,780,219 | D |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 20 Feb 2024 | Sale | 166,029 | 22.71 | 3,770,519 | D |
20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 20 Feb 2024 | Sale | 166,029 | 22.71 | 3,770,519 | I |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 16 Feb 2024 | Sale | 162,707 | 23.14 | 3,765,040 | D |
20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 16 Feb 2024 | Sale | 162,707 | 23.14 | 3,765,040 | I |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 23 Feb 2024 | Sale | 159,542 | 22.7 | 3,621,603 | I |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 23 Feb 2024 | Sale | 159,542 | 22.7 | 3,621,603 | D |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 21 Feb 2024 | Sale | 149,337 | 22.44 | 3,351,122 | I |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 21 Feb 2024 | Sale | 149,337 | 22.44 | 3,351,122 | D |
04 Jan 2024 21:49 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 04 Jan 2024 | Sale | 180,235 | 18.4 | 3,316,324 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 136,312 | 23.59 | 3,215,600 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 136,312 | 23.59 | 3,215,600 | D |
12 Aug 2024 16:05 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director | 08 Aug 2024 | Sale | 68,936 | 42.87 | 2,955,286 | I |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 22 Feb 2024 | Sale | 119,360 | 22.66 | 2,704,698 | I |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 22 Feb 2024 | Sale | 119,360 | 22.66 | 2,704,698 | D |
11 Oct 2022 09:00 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | See Remarks | 10 Oct 2022 | Sale | 195,800 | 12.46 | 2,439,668 | D |
11 Jun 2024 19:34 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 10 Jun 2024 | Sale | 80,000 | 30.24 | 2,419,200 | D |
12 Jun 2023 21:22 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | See Remarks | 12 Jun 2023 | Sale | 187,748 | 12.61 | 2,367,502 | D |
01 Mar 2024 21:38 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 01 Mar 2024 | Sale | 74,090 | 29.23 | 2,165,651 | D |
12 Aug 2024 16:05 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director | 09 Aug 2024 | Sale | 50,736 | 42.55 | 2,158,817 | I |
12 Aug 2024 16:05 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director | 09 Aug 2024 | Sale | 40,268 | 43.44 | 1,749,242 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 64,783 | 23.98 | 1,553,496 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 64,783 | 23.98 | 1,553,496 | D |
12 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 08 Mar 2024 | Sale | 55,208 | 26.72 | 1,475,158 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 08 Mar 2024 | Sale | 54,648 | 26.72 | 1,460,195 | D |
03 Jul 2024 21:00 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 21 Jun 2024 | Sale A | 29,787 | 35.01 | 1,042,843 | D |
24 Jun 2024 20:41 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 21 Jun 2024 | Sale | 29,787 | 35.01 | 1,042,843 | D |
12 Jun 2023 21:22 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | See Remarks | 09 Jun 2023 | Sale | 76,582 | 13.34 | 1,021,604 | D |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 11 Mar 2024 | Sale | 40,072 | 25.42 | 1,018,630 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 40,455 | 24.38 | 986,293 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 40,455 | 24.38 | 986,293 | I |
05 Mar 2024 17:07 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE OPPORTUNITY FUND I, L.P. | 10% | 01 Mar 2024 | Sale | 29,435 | 30.05 | 884,522 | D |
05 Mar 2024 17:08 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 01 Mar 2024 | Sale | 29,435 | 30.05 | 884,522 | I |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 08 Mar 2024 | Sale | 34,663 | 25.46 | 882,520 | D |
13 Jun 2024 21:45 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 12 Jun 2024 | Sale | 26,036 | 33.17 | 863,614 | D |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 21 Feb 2024 | Sale | 35,164 | 23.14 | 813,695 | I |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 21 Feb 2024 | Sale | 35,164 | 23.14 | 813,695 | D |
12 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 08 Mar 2024 | Sale | 30,755 | 25.31 | 778,409 | D |
04 Jan 2024 21:48 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 04 Jan 2024 | Sale | 42,453 | 18.13 | 769,673 | D |
04 Jan 2024 21:49 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 04 Jan 2024 | Sale | 38,301 | 19.05 | 729,634 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 08 Mar 2024 | Sale | 26,908 | 26.66 | 717,367 | D |
12 Aug 2024 16:05 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director | 08 Aug 2024 | Sale | 16,357 | 42.97 | 702,860 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 25,779 | 24.68 | 636,226 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 25,779 | 24.68 | 636,226 | D |
12 Jun 2023 21:22 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | See Remarks | 08 Jun 2023 | Sale | 46,811 | 13.15 | 615,565 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 23,505 | 24.38 | 573,052 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 23,505 | 24.38 | 573,052 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 22,567 | 24.83 | 560,339 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 22,567 | 24.83 | 560,339 | I |
22 May 2024 21:01 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 20 May 2024 | Sale | 17,134 | 32.49 | 556,684 | D |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 23 Feb 2024 | Sale | 23,648 | 22.7 | 536,810 | I |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 23 Feb 2024 | Sale | 23,648 | 22.7 | 536,810 | I |
01 Mar 2024 21:38 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 01 Mar 2024 | Sale | 18,976 | 28.25 | 536,072 | D |
15 Jun 2023 17:46 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 13 Jun 2023 | Sale | 40,000 | 12.89 | 515,600 | D |
05 Mar 2024 17:07 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE OPPORTUNITY FUND I, L.P. | 10% | 01 Mar 2024 | Sale | 17,099 | 30.05 | 513,825 | I |
05 Mar 2024 17:08 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 01 Mar 2024 | Sale | 17,099 | 30.05 | 513,825 | I |
26 Jan 2024 19:48 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 26 Jan 2024 | Sale | 19,822 | 24.52 | 486,035 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 20,205 | 23.59 | 476,636 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 20,205 | 23.59 | 476,636 | I |
13 Jun 2024 21:45 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 12 Jun 2024 | Sale | 13,964 | 33.7 | 470,587 | D |
04 Jan 2024 21:48 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 03 Jan 2024 | Sale | 24,583 | 19.05 | 468,306 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 11 Mar 2024 | Sale | 17,825 | 25.48 | 454,181 | D |
22 May 2024 21:01 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 20 May 2024 | Sale | 12,147 | 33.51 | 407,046 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 01 Mar 2024 | Sale | 14,103 | 28.25 | 398,410 | D |
04 Jan 2024 21:49 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 03 Jan 2024 | Sale | 19,775 | 19.03 | 376,318 | D |
03 Jul 2024 21:00 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 24 Jun 2024 | Sale A | 10,213 | 35.33 | 360,825 | D |
24 Jun 2024 20:41 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 24 Jun 2024 | Sale | 10,163 | 35.33 | 359,059 | D |
11 Jan 2023 16:56 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | See Remarks | 09 Jan 2023 | Sale | 30,150 | 11.57 | 348,836 | D |
04 Jan 2024 21:49 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 03 Jan 2024 | Sale | 16,026 | 20.5 | 328,533 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 13,109 | 24.83 | 325,496 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 13,109 | 24.83 | 325,496 | I |
26 Jan 2024 19:47 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 26 Jan 2024 | Sale | 13,000 | 24.34 | 316,420 | D |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 23 Feb 2024 | Sale | 13,738 | 22.7 | 311,853 | I |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 23 Feb 2024 | Sale | 13,738 | 22.7 | 311,853 | I |
04 Jan 2024 21:49 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 03 Jan 2024 | Sale | 15,382 | 18.34 | 282,106 | D |
04 Jan 2024 21:48 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 03 Jan 2024 | Sale | 15,382 | 18.34 | 282,106 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 11,736 | 23.59 | 276,852 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 11,736 | 23.59 | 276,852 | I |
12 Aug 2024 16:05 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director | 08 Aug 2024 | Sale | 6,377 | 40.74 | 259,799 | I |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 11 Mar 2024 | Sale | 9,928 | 26.1 | 259,121 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 01 Mar 2024 | Sale | 8,715 | 29.06 | 253,258 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 01 Mar 2024 | Sale | 8,747 | 28.22 | 246,840 | D |
04 Jan 2024 21:46 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 03 Jan 2024 | Sale | 13,000 | 18.81 | 244,530 | D |
11 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 07 Mar 2024 | Sale | 9,086 | 25.85 | 234,873 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 9,603 | 23.98 | 230,280 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 9,603 | 23.98 | 230,280 | I |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 11 Mar 2024 | Sale | 8,618 | 25.93 | 223,465 | D |
11 Mar 2024 21:52 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 07 Mar 2024 | Sale | 8,364 | 25.8 | 215,791 | D |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 11 Mar 2024 | Sale | 7,769 | 26.12 | 202,926 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)